EarningsQ4 2024 Earnings Report

Scinai Immunotherapeutics (2F50) Q4 2024 Earnings Report

0 Followers

DE:2F50 Q4 2024 EPS Results

Actual EPS-€7.10

Consensus EPS―

Beat/Miss―

One Year Ago EPS>-€0.01

Actual Revenue€520.18K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2024

Date05/07/2025

TimeAfter Close

Conference CallWednesday, May 7, 2025

DE:2F50 Upcoming Earnings

Scinai Immunotherapeutics's next earnings date is estimated for December 2, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 02, 2026	2026 (Q3)	- / -	-42.316	―
Aug 20, 2026	2026 (Q2)	- / -3.27	-15.678	79.16% (+12.41)
Jun 10, 2026	2026 (Q1)	- / 0.00	-7.101	―
Apr 01, 2026	2025 (Q4)	- / 8.54	-7.101	220.31% (+15.64)
Dec 02, 2025	2025 (Q3)	- / -42.32	0.019	-225919.05% (-42.33)
Sep 02, 2025	2025 (Q2)	- / -15.68	-0.018	-87750.00% (-15.66)
May 30, 2025	2025 (Q1)	- / -1.07	-0.009	-11840.00% (-1.06)
May 07, 2025	2024 (Q4)	- / -7.10	-0.009	-79480.00% (-7.09)
Nov 22, 2024	2024 (Q3)	- / 0.02	0.178	-89.50% (-0.16)
Aug 15, 2024	2024 (Q2)	- / -	-0.027	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed